Abstract
α-Synuclein, β-synuclein, and γ-synuclein range from 127 to 140 amino acids in length, and are 55%–62% identical in sequence with a similar domain organization. They are encoded by three genes located on chromosomes 4q23 ( SNCA ), 5q35 ( SNCB ), and 10q21 ( SNCC ). By immunohistochemistry, α- and β-synucleins are abundant and concentrated in nerve terminals, with little staining of cell bodies and dendrites. Ultrastructurally, they are found in close proximity to synaptic vesicles. In contrast, γ-synuclein is present throughout the nerve cells in many brain regions. For a long time, synucleins were believed to have little ordered structure. However, recent work has shown that native α-synuclein is a homotetramer with a predominantly α-helical conformation. Synucleins are only identified in vertebrates. A neurodegenerative pathway leading from soluble to insoluble, filamentous tau is central to the neurodegenerative process in the human tauopathies. The availability of animal models exhibiting the essential molecular and cellular features of the human diseases has opened the way to a detailed understanding of the neurodegenerative process and the identification of genetic and pharmacological modifiers. Besides hyperphosphorylation and aggregation, clearance of tau, immunotherapy, cell replacement, and microtubule stabilization are being pursued as potential therapies.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.